David J. Caponera
Corporate Officer/Principal at DICERNA PHARMACEUTICALS, INC.
Profile
David J.
Caponera is currently the Head of Patient Advocacy and Patient Services at Dicerna Pharmaceuticals, Inc. Previously, he worked as the VP of Patient Engagement and Access Support at Catalyst Pharmaceuticals, Inc. from 2014 to 2018.
He received his graduate degree from Duke University and his undergraduate degree from Cornell University.
David J. Caponera active positions
| Companies | Position | Start |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2019-06-12 |
Former positions of David J. Caponera
| Companies | Position | End |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2018-06-30 |
Training of David J. Caponera
| Duke University | Graduate Degree |
| Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- David J. Caponera
